AVENALI, MICOL
 Distribuzione geografica
Continente #
NA - Nord America 710
EU - Europa 428
AS - Asia 236
SA - Sud America 5
AF - Africa 2
OC - Oceania 2
Totale 1.383
Nazione #
US - Stati Uniti d'America 706
IE - Irlanda 225
CN - Cina 169
IT - Italia 82
SG - Singapore 43
FI - Finlandia 39
DE - Germania 33
CZ - Repubblica Ceca 8
NL - Olanda 8
FR - Francia 7
BE - Belgio 5
GB - Regno Unito 5
IN - India 5
JP - Giappone 5
RU - Federazione Russa 5
CA - Canada 4
BR - Brasile 3
KG - Kirghizistan 3
MY - Malesia 3
SE - Svezia 3
AT - Austria 2
AU - Australia 2
KR - Corea 2
AR - Argentina 1
BD - Bangladesh 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
ES - Italia 1
HK - Hong Kong 1
IR - Iran 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
RO - Romania 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.383
Città #
Dublin 215
Chandler 204
Boardman 70
Ashburn 45
Helsinki 36
Shanghai 35
Princeton 31
Lawrence 29
Medford 27
Beijing 26
Nanjing 25
Wilmington 25
Singapore 20
Milan 15
Hebei 14
Nanchang 13
New York 12
Rome 10
Fairfield 9
Seattle 9
Hangzhou 8
Amsterdam 7
Ann Arbor 7
Brno 7
Menlo Park 7
Shenyang 7
Chicago 6
Jacksonville 6
Los Angeles 6
Norwalk 6
Brussels 5
Changsha 5
Falls Church 5
Munich 5
Pune 5
Cagliari 4
Dallas 4
Messina 4
Pavia 4
Tokyo 4
Toronto 4
Washington 4
Bishkek 3
Ningbo 3
Piscataway 3
Pontoglio 3
Tianjin 3
Borås 2
Canberra 2
Como 2
Dearborn 2
Falkenstein 2
Frankfurt am Main 2
Guro-gu 2
Houston 2
Jiaxing 2
Naples 2
Naro-Fominsk 2
Osio Sotto 2
Paris 2
Redwood City 2
Santa Clara 2
Sittingbourne 2
Treviso 2
Vienna 2
Austin 1
Basiglio 1
Berlin 1
Bogotá 1
Böblingen 1
Cambridge 1
Castelraimondo 1
Centurion 1
Chelyabinsk 1
Cianorte 1
Cologne 1
Esslingen am Neckar 1
Ezeiza 1
Fort Worth 1
Germantown 1
Gāzipur 1
Handan 1
Hefei 1
Jacareí 1
Las Vegas 1
London 1
Madrid 1
Magenta 1
Nairobi 1
Olomouc 1
Pingdingshan 1
Rho 1
Rognano 1
Saint Paul 1
Shijiazhuang 1
St Petersburg 1
São Paulo 1
Taiyuan 1
Tashkent 1
Turi 1
Totale 1.076
Nome #
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism 67
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 64
CLINICAL AND BIOCHEMICAL SIGNATURES OF GBA-RELATED PARKINSON DISEASE 61
Consensus on the treatment of dysphagia in Parkinson's disease 60
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 56
Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project 55
Time for a consensus conference on pain in neurorehabilitation 55
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 53
Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study 52
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 51
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 48
KCTD17-related myoclonus-dystonia syndrome: clinical and electrophysiological findings of a patient with atypical late onset 45
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 45
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 44
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 42
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 42
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 41
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 37
Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations 35
Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes 34
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: A 6-year longitudinal study 34
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 32
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 32
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 30
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study 28
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 27
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 27
Reply to: “Increased alpha-Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations” 25
Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project 23
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 22
A narrative review on the role and main findings of the Videofluoroscopic Study of Swallowing in Parkison's disease 21
Evaluation of the efficacy of physical therapy on cognitive decline at 6-month follow-up in Parkinson disease patients with mild cognitive impairment: a randomized controlled trial 21
The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease 20
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease 16
Functional Study of SNCA p.V15A Variant: Further Linking α-Synuclein and Glucocerebrosidase 15
Proprioceptive Focal Stimulation (Equistasi®) May Improve the Quality of Gait in Middle-Moderate Parkinson's Disease Patients. Double-Blind, Double-Dummy, Randomized, Crossover, Italian Multicentric Study 14
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 13
Parkinson disease following COVID-19: Report of six cases 12
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 10
Pain in focal dystonias - A focused review to address an important component of the disease 6
Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects 5
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort 5
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 4
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study 4
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial 2
Exploring the neural and behavioral correlates of cognitive telerehabilitation in mild cognitive impairment with three distinct approaches 1
Bilateral Dentate Nuclei Hyperintensities and Response to 4-Aminopyridine in a Patient With Childhood-Onset GAA- FGF14 -Related Ataxia 1
Totale 1.437
Categoria #
all - tutte 8.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 1 0 0 2 10 7 10 0
2020/202148 0 1 16 2 3 4 0 11 6 3 1 1
2021/2022172 0 1 0 16 9 12 3 13 9 1 19 89
2022/2023549 54 54 5 67 31 40 1 22 251 3 15 6
2023/2024356 37 47 8 22 9 69 29 24 2 11 50 48
2024/2025169 38 57 21 20 33 0 0 0 0 0 0 0
Totale 1.437